A Florida biopharmaceutical and diagnostics company is paying nearly $1.5 billion in stock for Elmwood Park-based diagnostics laboratory firm Bio-Reference Laboratories Inc.OPKO Health Inc. said ...
Feel free to take Bio-Reference ( BRLI) at its word yet again. That's fine; hold onto that stock, regardless of its vulnerabilities. At least try to arrive at an informed decision, however, by ...
BioReference Health, formerly known as BioReference Laboratories, and OPKO Health have agreed to pay $9.85 million to resolve alleged violations of the False Claims Act arising from BioReference’s ...
ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) executed a Restitution Agreement with John Littleton, a former vice president in sales. Pursuant to the Agreement ...
MIAMI--(BUSINESS WIRE)--OPKO HEALTH, INC. (NYSE:OPK) and Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) today announced that the companies have signed a definitive merger agreement under which OPKO ...
Description: Founded in 1981, BioReference Laboratories is a clinical testing laboratory offering a comprehensive menu of services tapped by health care providers interested in the detection, ...
Scarlet brings diagnostic service to patients' homes, offices and other preferred locations, delivering an on-demand, safe and convenient diagnostic experience for patients and healthcare providers ...
Opko Health Inc. has agreed to acquire Bio-Reference Laboratories Inc. in a deal worth $1.47 billion. So What: Bio-Reference Labs is the nation's third largest laboratory services business, and its ...
BioReference Health LLC, formerly known as BioReference Laboratories Inc. (BioReference) and OPKO Health Inc. (OPKO), face a $704,349 government fine for medically unnecessary blood tests. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback